Abstract
Nowadays, big data is a widely utilized concept that has been spreading quickly in almost every domain. For pharmaceutical companies, using this concept is a challenging task because of the permanent pressure and business demands created through the legal requirements, research demands and standardization that have to be adopted. These legal and standards’ demands are associated with human healthcare safety and drug control that demands continuous and deep data analysis. Companies update their procedures to the particular laws, standards, market demands and regulations all the time by using contemporary information technology. This paper highlights some important aspects of the experience and change methodology used in one Macedonian pharmaceutical company, which has employed information technology solutions that successfully tackle legal and business pressures when dealing with a large amount of data. We used a holistic view and deliverables analysis methodology to gain top-down insights into the possibilities of big data analytics. Also, structured interviews with the company’s managers were used for information collection and proactive methodology with workshops was used in data integration toward the implementation of big data concepts. The paper emphasizes the information and knowledge used in this domain to improve awareness for the needs of big data analysis to achieve a competitive advantage. The main results are focused on systematizing the whole company’s data, information and knowledge and propose a solution that integrates big data to support managers’ decision-making processes.
References
[1] ALKASAP (2016), Alkaloid AD Skopje, http://www.alkaloid.com.mk/alkasap-en.nspx, 20.5.2016.Search in Google Scholar
[2] ACRM (2016), Alkaloid CRM system, http://www.alkaloid.com.mk/alkasap.nspx, 20.5.2016.Search in Google Scholar
[3] ASC (2016), Alkaloid Standard and control, http://www.alkaloid.com.mk/standards-and-controls.nspx, 20.5.2016.Search in Google Scholar
[4] Azarmi, B. (2016). Scalable Big Data Architecture. A Practitioner’s Guide to Choosing Relevant Big Data Architecture. Apress, Berkeley.10.1007/978-1-4842-1326-1Search in Google Scholar
[5] Berger C., Oracle Advanced Analytics 12c & SQLDEV/Oracle Data Miner 4.0, New Features, 2014Search in Google Scholar
[6] Carter, K. B. (2014). Actionable Intelligence: A Guide to Delivering Business Results with Big Data Fast!. John Wiley & Sons.10.1002/9781118925331Search in Google Scholar
[7] Chen, H., Chiang, R. H., & Storey, V. C. (2012). Business intelligence and analytics: From big data to big impact. MIS quarterly, 36(4).10.2307/41703503Search in Google Scholar
[8] Macedonian Agency for medicines and medicine devices, http://malmed.gov.mk/index.php/2015-07-11-10-47-48, 12.5.2016.Search in Google Scholar
[9] MPES (2014), Platforms and Algorithms for Big Data Analytics, MyPharmaExpert Suite, Infotehna group LLC, http://cdn.ddfevent.com/pdf/SinisaBelina_2014.pdf, 14.2.2014Search in Google Scholar
[10] Dupin-Bryant, P. A., & Olsen, D. H. (2014). Business intelligence, analytics and data visualization: A heat map project tutorial. International Journal of Management & Information Systems (IJMIS), 18(3), 185-200.10.19030/ijmis.v18i3.8705Search in Google Scholar
[11] Kessel, P. V. (2014). Big data changing the way businesses compete and operate. Insights on governance, risk and compliance, EYSearch in Google Scholar
[12] Gandomi, A., & Haider, M. (2015). Beyond the hype: Big data concepts, methods, and analytics. International journal of information management, 35(2), 137-144.10.1016/j.ijinfomgt.2014.10.007Search in Google Scholar
[13] Hazen, B. T., Boone, C. A., Ezell, J. D., & Jones-Farmer, L. A. (2014). Data quality for data science, predictive analytics, and big data in supply chain management: An introduction to the problem and suggestions for research and applications. International Journal of Production Economics, 154, 72-80.10.1016/j.ijpe.2014.04.018Search in Google Scholar
[14] Kwon, O., Lee, N., & Shin, B. (2014). Data quality management, data usage experience and acquisition intention of big data analytics. International journal of information management, 34(3), 387-394.10.1016/j.ijinfomgt.2014.02.002Search in Google Scholar
[15] NVP Survey (2014), Big Data Executive Survey 2014, An Update on the Progress of Big Data in the Large Corporate World, www.newvantage.com, 10.4.2016Search in Google Scholar
[16] Oracle Inc., (2013) Oracle data sheet, Powerful Visual Analytics for the Entire Organization Oracle Business Intelligence 12cSearch in Google Scholar
[17] Reddy C.K. (2013), Platforms and Algorithms for Big Data Analytics, Wayne State university, http://dmkd.cs.vt.edu/TUTORIAL/Bigdata/, 12.5.2016Search in Google Scholar
[18] Seebode, C., Ort, M., Regenbrecht, C., & Peuker, M. (2013, October). BIG DATA infrastructures for pharmaceutical research. In 2013 IEEE International Conference on Big Data (pp. 59-63). IEEE.10.1109/BigData.2013.6691759Search in Google Scholar
[19] Economist (2014), The Economist, View from the C-suite, Who’s big on BIG DATA, The Economist Intelligence Unit Limited 2014Search in Google Scholar
[20] Vance J., (2014), Big Data 50, http://startup50.com/wp-content/uploads/2014/10/BD50_Startups_V1.1.pdf, 2.6.2016Search in Google Scholar
[21] Stodder, D. (2013). Data visualization and discovery for better business decisions. TDWI Research.Search in Google Scholar
[22] Dubey, R., Gunasekaran, A., Childe, S. J., Wamba, S. F., & Papadopoulos, T. (2016). The impact of big data on world-class sustainable manufacturing. The International Journal of Advanced Manufacturing Technology, 84(1-4), 631-645.10.1007/s00170-015-7674-1Search in Google Scholar
[23] Janga, S. C., Zhu, D., Chen, J. Y., & Zaki, M. J. (2015). Knowledge Discovery Using Big Data in Biomedical Systems [Guest Editorial]. IEEE/ACM transactions on computational biology and bioinformatics, 12(4), 726-728.10.1109/TCBB.2015.2454551Search in Google Scholar PubMed
[24] Stojanovic, N., Dinic, M., & Stojanovic, L. (2015, October). Big data process analytics for continuous process improvement in manufacturing. In 2015 IEEE International Conference on Big Data (Big Data) (pp. 1398-1407). IEEE.10.1109/BigData.2015.7363900Search in Google Scholar
[25] Jokonya, O. (2015, November). Towards a conceptual framework for big data adoption in organizations. In 2015 International Conference on Cloud Computing and Big Data (CCBD) (pp. 153-160). IEEE.10.1109/CCBD.2015.59Search in Google Scholar
[26] Kanchi, S., Sandilya, S., Ramkrishna, S., Manjrekar, S., & Vhadgar, A. (2015, August). Challenges and Solutions in Big Data Management–An Overview. In 2015 3rd International Conference on Future Internet of Things and Cloud (pp. 418-426). IEEE.10.1109/FiCloud.2015.121Search in Google Scholar
[27] Cui, L., Tao, S., & Zhang, G. Q. (2016). Biomedical ontology quality assurance using a big data approach. ACM Transactions on Knowledge Discovery from Data (TKDD), 10(4), 41.10.1145/2768830Search in Google Scholar
[28] Fang, R., Pouyanfar, S., Yang, Y., Chen, S. C., & Iyengar, S. S. (2016). Computational health informatics in the big data age: a survey. ACM Computing Surveys (CSUR), 49(1), 12.10.1145/2932707Search in Google Scholar
[29] Gorton, I., & Klein, J. (2014). Distribution, data, deployment: Software architecture convergence in big data systems. IEEE Software, 32(3), 78-85.10.1109/MS.2014.51Search in Google Scholar
[30] Macedonian Stock Exchange, http://www.mse.mk/mk/symbol/ALK, 10.10.2016.Search in Google Scholar
[31] Ristevski, B., & Chen, M. (2018). Big data analytics in medicine and healthcare. Journal of integrative bioinformatics, 15(3).10.1515/jib-2017-0030Search in Google Scholar PubMed PubMed Central
[32] Fan, J., & Liu, H. (2013). Statistical analysis of big data on pharmacogenomics. Advanced drug delivery reviews, 65(7), 987-1000.10.1016/j.addr.2013.04.008Search in Google Scholar PubMed PubMed Central
[33] Cordon, C., Garcia-Milà, P., Vilarino, T. F., & Caballero, P. (2016). Serialization in the pharmaceutical industry. In Strategy is Digital (pp. 47-64). Springer, Cham.10.1007/978-3-319-31132-6_3Search in Google Scholar
[34] Horalek, J., & Sobeslav, V. (2017, August). Track & Trace System with Serialization Prototyping Methodology for Pharmaceutical Industry in EU. In International Conference on Mobile Web and Information Systems (pp. 177-186). Springer, Cham.10.1007/978-3-319-65515-4_15Search in Google Scholar
[35] Kumar, S., & Singh, M. (2018). Big data analytics for healthcare industry: impact, applications, and tools. Big Data Mining and Analytics, 2(1), 48-57.10.26599/BDMA.2018.9020031Search in Google Scholar
[36] Brown, N., Cambruzziet al., (2018). Big data in drug discovery. In Progress in medicinal chemistry (Vol. 57, pp. 277-356). Elsevier.10.1016/bs.pmch.2017.12.003Search in Google Scholar PubMed
[37] Costa, F. F. (2014). Big data in biomedicine. Drug discovery today, 19(4), 433-440.10.1016/j.drudis.2013.10.012Search in Google Scholar PubMed
[38] Schneider, N., Lowe, D. M., Sayle, R. A., Tarselli, M. A., & Landrum, G. A. (2016). Big data from pharmaceutical patents: a computational analysis of medicinal chemists’ bread and butter. Journal of medicinal chemistry, 59(9), 4385-4402.10.1021/acs.jmedchem.6b00153Search in Google Scholar PubMed
[39] Chircu, A. M., Sultanow, E., & Chircu, F. C. (2014, June). Cloud computing for big data entrepreneurship in the supply chain: using SAP HANA for pharmaceutical track-and-trace analytics. In 2014 IEEE World Congress on Services (pp. 450-451). IEEE.10.1109/SERVICES.2014.84Search in Google Scholar
[40] Tetko, I. V., Engkvist, O., Koch, U., Reymond, J. L., & Chen, H. (2016). BIGCHEM: challenges and opportunities for big data analysis in chemistry. Molecular informatics, 35(11-12), 615-621.10.1002/minf.201600073Search in Google Scholar PubMed PubMed Central
[41] Elhoseny, M., Abdelaziz, A., Salama, A. S., Riad, A. M., Muhammad, K., & Sangaiah, A. K. (2018). A hybrid model of internet of things and cloud computing to manage big data in health services applications. Future generation computer systems, 86, 1383-1394.10.1016/j.future.2018.03.005Search in Google Scholar
[42] Dennis, K. K., et al. (2016). Biomonitoring in the era of the expo-some. Environmental health perspectives, 125(4), 502-510.10.1289/EHP474Search in Google Scholar PubMed PubMed Central
[43] Ramharack, P., & Soliman, M. E. (2018). Bioinformatics-based tools in drug discovery: the cartography from single gene to integrative biological networks. Drug discovery today, 23(9), 1658-1665.10.1016/j.drudis.2018.05.041Search in Google Scholar PubMed
[44] Sallam, R. L., Tapadinhas, J., Parenteau, J., Yuen, D., & Hostmann, B. (2014). Magic quadrant for business intelligence and analytics platforms. Gartner RAS core research notes. Gartner, Stamford, CT.Search in Google Scholar
[45] Howson, C., Sallam, R. L., Richardson, J. L., Tapadinhas, J., Idoine, C. J., & Woodward, A. (2018). Magic quadrant for analytics and business intelligence platforms. Retrieved Aug, 16, 2018.Search in Google Scholar
[46] Farmabrend Nova, Association of Foreign Innovative Pharmaceuticals Manufacturers Representatives, Code of Farmabrend Nova’s Conduct During Promotion of Drugs Issued Under a Prescription and Communication Towards the Healthcare Professionals, 06.2018, https://www.efpia.eu/media/412640/macedonia_national-code.pdf?fficlid=IwAR27HfxLgLUhXNgR4gM7PQ7iaUE0SSdNkPoRU7OYxoqOH2V22w0rQv0vkvI, accessed 20.2.2020.Search in Google Scholar
[47] European Federation of Pharmaceutical Industries and Associations (EFPIA) https://www.efpia.eu/, accessed 20.2.2020.Search in Google Scholar
© 2020 Snezana Savoska et al., published by De Gruyter
This work is licensed under the Creative Commons Attribution 4.0 International License.
